Clinical Trial Outsourcing Market Expected To Reach USD 111.01 Billion by 2032, Growing at a CAGR of 8.7% From 2024-2032 | Introspective Market Research
December 19, 2024 06:27 ET
|
Introspective Market Research
United Kingdom, London, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Australian healthcare technology company Resonance Health completed the acquisition of 100% of clinical research center TrialsWest for a...
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
December 17, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
TransCode Therapeutics Open Letter to Shareholders
November 12, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
Open Letter to Shareholders
DNA Sequencing Market Size to Hit USD 74.89 Billion by 2033 | Straits Research
November 11, 2024 10:15 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Nov. 11, 2024 (GLOBE NEWSWIRE) -- DNA sequencing is the process of determining the exact order of nucleotides (adenine, thymine, cytosine, and guanine) in a DNA molecule....
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 08, 2024 10:05 ET
|
Compass Therapeutics
New data showed a correlation between the levels of neural cell adhesion molecule (NCAM or CD56) expression and response and disease control in patients treated with CTX-471 monotherapy.Predictive...
Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This Week
October 22, 2024 14:30 ET
|
Tevogen Bio Inc
WARREN, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
CenTrak Named Global Healthcare RTLS Company of the Year by Frost & Sullivan
October 10, 2024 09:05 ET
|
CenTrak, Inc.
CenTrak recognized as a global RTLS leader for its scalable location data and comprehensive suite of solutions on a unified platform
Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution
October 08, 2024 07:05 ET
|
Amwell
Amwell today announced Hello Heart is a partner in the Amwell clinical programs portfolio available on the Amwell Converge™ platform.
Temperature Monitoring Devices Market to be Worth USD 5.3 billion by 2034, growing a CAGR 4.5% - Transparency Market Research, Inc.
October 01, 2024 08:55 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The global temperature monitoring devices market (온도 모니터링 장치 시장) is estimated to surge at...
CytoMed Therapeutics Reports Six Months Ended June 30, 2024 Financial Results and Provides Clinical and Corporate Updates
September 30, 2024 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
Conference call via Zoom is scheduled for October 8, 2024 at 9 a.m. ET (9 p.m. SGT) https://us06web.zoom.us/meeting/register/tZMrcOmppj0sGdA37lASywTyixRflo9w1TZT SINGAPORE, Sept. 30, 2024 (GLOBE...